期刊文献+
共找到205篇文章
< 1 2 11 >
每页显示 20 50 100
Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3 被引量:13
1
作者 Feng-Tian He Rong-Fen Li Yun-Sheng Kang Yan Zhang,Department of Biochemistry & Molecular Biology,Third Military Medical University,Chongqing 400038,China Yong-Zhan Nie Bao-Jun Chen Tai-Dong Qiao Dai-Ming Fan,Institute of Digestive Disease,Xijing Hospital,Fourth Military Medical University,Xi’an 710032,Shaanxi Province,China 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第2期258-262,共5页
AIM: To generate soluble single chain variable fragments (ScFv) of monoclonal antibody MC3 recognizing colorectal and gastric carcinomas. METHODS: mRNA was isolated from the hybridoma cell line producing MC3 and the D... AIM: To generate soluble single chain variable fragments (ScFv) of monoclonal antibody MC3 recognizing colorectal and gastric carcinomas. METHODS: mRNA was isolated from the hybridoma cell line producing MC3 and the DNAs encoding variable domains of heavy and light chains (VH and VL) of the antibody were amplified separately by RT-PCR and assembled into ScFv DNA with a linker DNA. The ScFv DNA was ligated into the phagemid vector pCANTAB5E and the ligated sample was transformed into E.coli TG1.The transformed cells were infected with M13KO7 helper phage to yield recombinant phages. After two rounds of panning with gastric carcinoma cell line AGS highly expressing MC3-binding antigen, the phage clones displaying ScFv fragments of the antibody were selected by ELISA. 4 phage clones showing strong signal in ELISA were used to infect E.coli HB2151 to express soluble ScFvs. The soluble ScFvs were identified by Dot blot and Western blot, and their antigen-binding activity was assayed by ELISA. The VH and VL DNAs of the ScFv DNA derived from phage clone 19 were sequenced. RESULTS: The VH,VL and ScFv DNAs were about 340 bp, 320 bp and 750 bp respectively. After two rounds of panning to the recombinant phages, 18 antigen-positive phage clones were selected from 30 preselected phage clones by ELISA. All the soluble ScFvs derived from the 4 out of the 18 antigen-positive phage clones were about M(r)32000 and concentrated in periplasmatic space under the given culture condition. The soluble ScFvs could bind the antigen, and they shared the same binding site with MC3. The sequences of the VH and VL DNAs of the MC3 ScFv showed that the variable antibody genes belonged to the IgG1 subgroup,kappa-type. CONCLUSION: The soluble ScFv of MC3 is successfully produced, which not only provides a possible novel targeting vehicle for in vivo and in vitro study on associated cancers, but also offers the antibody a stable genetic source. 展开更多
关键词 Animals Antibodies monoclonal Base Sequence Carcinoma Colorectal Neoplasms Enzyme-Linked Immunosorbent Assay Humans Immunoglobulin Fragments Immunoglobulin Variable Region Mice Molecular Sequence Data recombinant Proteins Stomach Neoplasms Tumor Cells Cultured
下载PDF
PURIFICATION OF RECOMBINANT HUMAN INTERFERON-γ BY IMMUNOAFFINITY CHROMATOGRAPHY WITH MONOCLONAL ANTIBODY
2
作者 丛进阳 陈薇 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 1995年第3期4-12,共9页
E.coli cells expressing recombinant human interferon-γ was disrupted by sonication anddissolved in 7mol·L<sup>-1</sup> guanidine hydrochloride.The extract obtained was then renaturated by 70 folddilu... E.coli cells expressing recombinant human interferon-γ was disrupted by sonication anddissolved in 7mol·L<sup>-1</sup> guanidine hydrochloride.The extract obtained was then renaturated by 70 folddilution with PBS.HulFN γ was purified by affinity chromatography with monoclonal antibody fromthe renaturated crude feed solution.After washing the column with PBS,the adsorbed HulFN γ waseluted with PBS containing 0.5mol·L<sup>-1</sup> NaCl.The column was regenerated with 2mol·L<sup>-1</sup> GuHClfor reuse.After one step of affinity purification the purity of interferon-γ was over 95%.and thespecific activity of the HulFN-γ reached 1.2×10<sup>7</sup> IU·mg<sup>-1</sup> protein.92.8% of recovery was obtainedin the elution step.Total recovery of HulFN γ activity in the affinity chromatography was 78%. 展开更多
关键词 monoclonal antibody AFFINITY chromatographv recombinant human INTERFERON
下载PDF
Production and Characterization of Monoclonal Antibody Against Recombinant Human Erythropoietin
3
作者 JIE-BO MI JIN YAN +3 位作者 XIAO-JIE DING ZHEN-QUAN GUO MEI-PING ZHAO WEN-BAO CHANG 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2007年第3期184-188,共5页
Objective To produce specific monoclonal antibody (mAb) against recombinant human erythropoietin (rHuEPO) for development of highly efficient methods for erythropoietin detection in biological fluids. Methods rHuE... Objective To produce specific monoclonal antibody (mAb) against recombinant human erythropoietin (rHuEPO) for development of highly efficient methods for erythropoietin detection in biological fluids. Methods rHuEPO was covalently coupled with bovine serum albumin (BSA) and the conjugate was used to immunize mice to produce specific mAb against rHuEPO based on hybridoma technology. The obtained F3-mAb was characterized by enzyme-linked irmnunosorbent assay (ELISA), SDS-PAGE and Western blot. Results The isotype of F3-mAb was found to be IgM with an affinity constant of 2.1x10s L/mol. The competitive ELISA using the obtained IgM showed a broader linear range and lower detection limit compared with previous work. Conclusions The modification of rHuEPO was proved to be successful in generating required specific mAb with high avidity to rHuEPO. 展开更多
关键词 recombinant human erythropoietin monoclonal antibody IGM ELISA
下载PDF
SYNTHESIS OF INTERFERON-α_A MONOCLONAL ANTIBODY PACKING MATERIAL IN HIGH-PERFORMANCE AFFINITY CHROMATOGRAPHY AND PURIFICATION OF RECOMBINANT HUMAN INTERFERON-α_A
4
作者 Wen Ke FENG Xin Du GENG Laboratory of Modern Separation Science, Department of Chemistry Northwest University, Xi’an 710069 《Chinese Chemical Letters》 SCIE CAS CSCD 1991年第5期383-386,共4页
A new way for the synthesis of human interferon—α_A monoclonal antibody (IFN-α_A-McAb) bound to silica gel packing material in high-performance affinity chromatography (HPAFC) has been developed. The high coupling ... A new way for the synthesis of human interferon—α_A monoclonal antibody (IFN-α_A-McAb) bound to silica gel packing material in high-performance affinity chromatography (HPAFC) has been developed. The high coupling efficiency and specific activity of IFN—α_A-McAb can be obtained by activated diol-silica gel with activating agent. After purification using this packing material in HPAFC, the specific activity of recombinant human interferon-α_A (rIFN-α_A) rose up to 1.03×10~7IU/mg protein and the purification efficiency is appoximately 100 times. 展开更多
关键词 IFN SYNTHESIS OF INTERFERON A monoclonal antibody PACKING MATERIAL IN HIGH-PERFORMANCE AFFINITY CHROMATOGRAPHY AND PURIFICATION OF recombinant HUMAN INTERFERON
下载PDF
Preparation of Monoclonal Antibody against P65 Protein of Mycoplasma hyopneumoniae
5
作者 刘茂军 张悦 +2 位作者 白昀 王海燕 邵国青 《Agricultural Science & Technology》 CAS 2014年第11期1872-1875,1907,共5页
P65 protein, the major immunodominant protein of Mycoplasma hyopneu-moniae (Mhp) exhibiting no cross-reaction with other mycoplasmas, is general y used as a target protein for Mhp detection. In this study, BALB/c mi... P65 protein, the major immunodominant protein of Mycoplasma hyopneu-moniae (Mhp) exhibiting no cross-reaction with other mycoplasmas, is general y used as a target protein for Mhp detection. In this study, BALB/c mice were immunized with prokaryotical y expressed P65 recombinant protein to prepare monoclonal anti-body. After screening with Mhp whole-cel protein and P65 protein, a specific hy-bridoma cel line, 3G12, was obtained by ELISA. Identification results indicated that the antibody secreted by 3G12 hybridoma cel s could react with P65 protein and Mhp whole-cel protein. According to indirect ELISA assay, 3G12 cel culture super-natant possessed a titer of 1∶12 800 against P65 protein and 1∶3 200 against Mhp whole-cel protein; 3G12 ascites possessed a titer of above 1∶4 000 000 against P65 protein and above 1∶20 000 against Mhp 168 whole-cel protein. After long-term in vitro culture and continuous freezing-thawing, 3G12 cel line could stably secrete antibodies. A monoclonal antibody against P65 protein and Mhp whole-cel protein was successful y obtained in the present study, which provided basis for further in-vestigating the pathogenic mechanism of Mhp and establishing diagnostic methods of Mycoplasmal pneumonia of swine (MPS). 展开更多
关键词 Mycoplasma hyopneumoniae(Mhp) P65 recombinant protein monoclonal antibody
下载PDF
Application of GP5 Protein to Develop Monoclonal Antibody against Porcine Reproductive and Respiratory Syndrome Virus 被引量:2
6
作者 Hong Tian Yan Cheng Jin-yang Wu Jian-hui He You-jun Shang Xiang-tao Liu 《Virologica Sinica》 SCIE CAS CSCD 2011年第4期267-272,共6页
In this study, a panel of monoclonal antibodies (mAbs) against Porcine reproductive and respiratory syndrome virus(PRRSV), named as 8C9 and4B4, were produced by fusing SP2/0 myeloma cells and spleen cells of BALB/... In this study, a panel of monoclonal antibodies (mAbs) against Porcine reproductive and respiratory syndrome virus(PRRSV), named as 8C9 and4B4, were produced by fusing SP2/0 myeloma cells and spleen cells of BALB/c mice immunized with the PRRSV (TCID50=5.5), screened by the indirect ELISA and subjected to several limiting dilutions, mAbs were then identified by biological characterization. Among the two fusion cell strains, 8C9 belonged to the IgG1 subclass and 4B4 belonged to the IgG2a subclass. The titers in cell culture supematant and abdomen liquor reached to 1:104and 1:105, respectively. The specificity test indicated that the two cells had specific reactions for the PRRSV and GP5 protein respectively, and no reaction with Classical swine fever virus (CSFV) or Swine vesicular disease virus (SVDV). The molecular weights of the heavy chain and light chain were about 45.0 kDa and 25.0 kDa, respectively. In neutralization activity tests, the results showed that the prepared mAb 4B4 can protect 50% of cells with no CPE in dilution up to 1:512, but mAB 8C9 has no neutralization activities to PRRSV. 展开更多
关键词 Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant GP5 protein monoclonal antibody
下载PDF
Characterization and Diagnostic Use of a Monoclonal Antibody for VP28 Envelope Protein of White Spot Syndrome Virus
7
作者 Chong-lin Hou Yu Cao +2 位作者 Rong-hui Xie Yi-zhen Wang Hua-hua Du 《Virologica Sinica》 SCIE CAS CSCD 2011年第4期260-266,共7页
The gene encoding the VP28 envelope protein of White spot syndrome virus (WSSV) was cloned into expression vector pET-30a and transformed into the Escherichia coli strain BL21.After induction,the recombinant VP28 (rVP... The gene encoding the VP28 envelope protein of White spot syndrome virus (WSSV) was cloned into expression vector pET-30a and transformed into the Escherichia coli strain BL21.After induction,the recombinant VP28 (rVP28) protein was purified and then used to immunize Balb/c mice for monoclonal antibody (MAb) production.It was observed by immuno-electron microscopy the MAbs specific to rVP28 could recognize native VP28 target epitopes of WSSV and dot-blot analysis was used to detect natural WSSV infection.Competitive PCR showed that the viral level was approximately 104 copies/mg tissue in the dilution of gill homogenate of WSSV-infected crayfish at the detection limit of dot-blot assay.Our results suggest that dot-blot analysis with anti-rVP28 MAb could rapidly and sensitively detect WSSV at the early stages of WSSV infection. 展开更多
关键词 White spot syndrome virus (WSSV) recombinant VP28 monoclonal antibody (MAb)
下载PDF
THE DEVELOPMENT OF MONOCLONAL ANTIBODY AGAINST rhTNF AND ITS CURATIVE EFFECTSON E.Coli INFECTED MICE
8
作者 郭小清 王爱霞 +1 位作者 陈实平 邱志峰 《Chinese Medical Sciences Journal》 CAS CSCD 1997年第4期229-231,共3页
Fifteen hybridoma cell lines producing monoclonal antiboclies (McAb) against recombinant human tu-mor necrosis factor a (rhTNFa) have been established by fusing SP 2/0 cells with spleen cells from aBALB/c mouse immuni... Fifteen hybridoma cell lines producing monoclonal antiboclies (McAb) against recombinant human tu-mor necrosis factor a (rhTNFa) have been established by fusing SP 2/0 cells with spleen cells from aBALB/c mouse immunized with rhTNFa. Following J M Davis’s Works, semi-solid medium was usedfor initial cloning. Five of them were studied further. Their main chromosome- numbers range were 96 to105, all of them were IgG1 subclass. The affinities of these McAbs were estimated to be 1. 25 ×108 mol/L, 1. 12×108 mol/L, 2. 34×108 mol/L, 8. 55 × 107 mol/L, 1. 04×108 mol/L, respectively.Two groups of mice challenging with E Coli (107 organisms), one group treated with 2mg/kg anti-TNF monoclonal antibody, the other did not. There was a higher survival rate in treated group, the serumTNF level was significantly lower too, and the untreated mice had severe pathologic changes in vlscera. 展开更多
关键词 recombinant human tumor necrosis factor α hybridoma cell monoclonal antibody (McAb )
全文增补中
猪圆环病毒3型Cap蛋白单克隆抗体的制备及阻断ELISA检测方法的建立 被引量:1
9
作者 张宝戈 黄雅琴 +2 位作者 蔡金双 朱晨光 李玉峰 《畜牧兽医学报》 CAS CSCD 北大核心 2024年第3期1170-1178,共9页
旨在建立检测猪圆环病毒3型(PCV3)抗体的阻断ELISA方法,本研究利用原核表达的PCV3Cap重组蛋白免疫BALB/c小鼠制备获得了一株分泌阻断效果良好抗体的杂交瘤细胞株2E6。以重组Cap蛋白作为包被抗原,以辣根过氧化物酶(HRP)标记的2E6单克隆... 旨在建立检测猪圆环病毒3型(PCV3)抗体的阻断ELISA方法,本研究利用原核表达的PCV3Cap重组蛋白免疫BALB/c小鼠制备获得了一株分泌阻断效果良好抗体的杂交瘤细胞株2E6。以重组Cap蛋白作为包被抗原,以辣根过氧化物酶(HRP)标记的2E6单克隆抗体作为检测抗体,经条件优化后建立了一种检测PCV3抗体的阻断ELISA方法。用建立的阻断ELISA方法检测50份临床阴性血清,计算阻断率(PI)的临界值,以此来确定该方法的判定标准:当PI≤28.30%时,判定结果为阴性;当PI≥35.05%时,判定结果为阳性;当28.30%<PI<35.05%时,判定为可疑,重复一次试验后如果结果仍为可疑,则判定为阳性。特异性试验表明该方法与猪圆环病毒2型(PCV2)、猪伪狂犬病病毒(PRV)、猪繁殖与呼吸综合征病毒(PRRSV)以及猪瘟病毒(CSFV)的阳性血清均无交叉反应;敏感性试验表明其检测效价可达到1:128;重复性试验表明批内与批间的变异系数均小于10%;符合性检验表明该方法与PCV检测金标准免疫过氧化物酶单层试验(IPMA)比对的Kappa值达0.9,具有高度的一致性。综上所述,本研究建立的阻断ELISA方法具有良好的特异性与较高的符合率,可用于后期进行PCV3抗体的检测,为PCV3的流行病学调查与临床诊断提供技术支持。 展开更多
关键词 猪圆环病毒3型 Cap重组蛋白 单克隆抗体 阻断ELISA
下载PDF
DEVELOPMENT OF GENETICALLY ENGINEERED MOUSE/HUMAN CHIMERIC AND SINGLE CHAIN ANTIBODIES AGAINST HUMAN BRAIN GLIOMA:A PRELIMINARY REPORT 被引量:1
10
作者 黄强 沈树泉 许志元 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 1997年第1期11-15,共5页
In order to improve the clinical usefulness of mAb of mouse origin in targeting diagnosis and therapy for human brain glioma, it is necessary to humanize it and reduce its molecular size. By means of RT-PCR technique,... In order to improve the clinical usefulness of mAb of mouse origin in targeting diagnosis and therapy for human brain glioma, it is necessary to humanize it and reduce its molecular size. By means of RT-PCR technique, a 348 bp heavy chain variable domain (VH),and a 318 bp light chain variable domain (VL) cDNA fragments were cloned from mouse hybridoma cell line SZ39 secreting mAb against human brain glioma. By recombinant DNA technique, the two cDNA 'fragments were linked to human IgGI heavy chain CHI and light chain K constant regions, respectively, to form a mouse/human chimeric gene which was then inserted into an expression vector pHENI-SZ39 Fab/Hu. In addition,the two cDNA fyagments were linked directly with a universal link6r and inserted into an expression vector pHENI-SZ39ScFv. The two expression vectors were separately introduced into non-suppressor E.coli HB2151to secrete chimeric antibodies and single-chain antibodies,respectively. On ELISA and Western blot assays, the two genetically engineered antibodies were bound specifically to the same 180 kD cell surface membrane antigen on human brain glioma cell line SHG44 as did the parental mAb SZ39. 展开更多
关键词 monoclonal antibody GLIOMA Genetic recombination
下载PDF
赭曲霉毒素A单克隆抗体的体外制备及其重组抗体的构建研究 被引量:1
11
作者 李蓉芳 吴箫 +3 位作者 王何瑶 盛玲 张珍 何庆华 《食品安全质量检测学报》 CAS 北大核心 2023年第6期118-126,共9页
目的实现抗赭曲霉毒素A(ochratoxinA,OTA)单克隆抗体的体外制备及其重组抗体表达载体的构建与瞬时转染表达。方法以前期获得的OTA杂交瘤细胞株(O16)为研究对象,通过无血清驯化培养的方式开展OTA单克隆抗体的体外制备研究;采用简并引物... 目的实现抗赭曲霉毒素A(ochratoxinA,OTA)单克隆抗体的体外制备及其重组抗体表达载体的构建与瞬时转染表达。方法以前期获得的OTA杂交瘤细胞株(O16)为研究对象,通过无血清驯化培养的方式开展OTA单克隆抗体的体外制备研究;采用简并引物法获取OTA杂交瘤细胞的单克隆抗体编码基因,在此基础上构建OTA重组全长抗体表达载体以及OTA重、轻链可变区基因片段与人源恒定区片段连接的重组嵌合抗体表达载体,并基于哺乳动物细胞系,开展两种重组抗体的瞬时转染表达研究。结果通过缓降血清浓度的方式对OTA杂交瘤细胞进行无血清驯化,实现了体外培养制备OTA单克隆抗体;在此基础上测得OTA单克隆抗体的重链和轻链基因序列,并成功构建了OTA重组全长抗体表达载体(pCDNA3.4-OTA-H/L)和重组嵌合抗体表达载体(p FUSE-OTA-H/L),通过共转染实现了两者在哺乳动物细胞系中的瞬时转染表达;经间接酶联免疫吸附测定(enzyme linked immunosorbent assay,ELISA)确定体外培养制备的OTA抗体、OTA重组全长抗体和嵌合抗体均具备特异性结合抗原的能力,三者的线性检测范围分别为1.043~1.671、0.944~1.245、1.387~1.902 ng/mL,均保留了对OTA的特异性结合能力。结论通过缓降血清的方式得到了适应无血清培养的OTA杂交瘤细胞,进而实现了体外培养制备OTA单克隆抗体;成功构建了OTA全长重组抗体及人源嵌合抗体的表达载体,并在哺乳动物细胞中实现了其重组抗体的瞬时转染表达。 展开更多
关键词 赭曲霉毒素A 单克隆抗体 重组抗体 真核表达
下载PDF
基于哺乳动物细胞表达S1蛋白的猪流行性腹泻病毒单克隆抗体 被引量:1
12
作者 李虎林 颜仁和 +7 位作者 陈泽典 仇珍珍 李堪贺 马曼欣 毛莹莹 李建军 吕宗吉 李红卫 《分子诊断与治疗杂志》 2023年第4期694-698,共5页
目的 制备抗猪流行性腹泻病毒的单克隆抗体。方法 本研究以哺乳动物细胞293T表达的PEDV S1重组蛋白免疫BALB/c小鼠;利用细胞融合技术,经间接ELISA方法筛选和细胞克隆,得到5株能稳定分泌抗PEDV S1单克隆抗体的杂交瘤细胞株。筛选效价最... 目的 制备抗猪流行性腹泻病毒的单克隆抗体。方法 本研究以哺乳动物细胞293T表达的PEDV S1重组蛋白免疫BALB/c小鼠;利用细胞融合技术,经间接ELISA方法筛选和细胞克隆,得到5株能稳定分泌抗PEDV S1单克隆抗体的杂交瘤细胞株。筛选效价最高的杂交次瘤细胞株制备单克隆抗体并进行特性鉴定。结果 免疫小鼠的脾细胞和SP2/0骨髓瘤细胞融合后,经多次克隆及亚克隆筛选,共得到5株能与PEDV S1蛋白产生特异性反应的单抗表达细胞株。分别命名为:12D14H4、13F5B9、10D2B10、11A7C9和14E6F5,其分泌的抗体效价分别为:1∶51 200、1∶25 600、1∶12800、1∶12 800、1∶3 200。5株单抗与PEDV S1蛋白反应后,均在130 KDa附近出现清晰条带。所得单克隆抗体为IgGⅠ亚型,轻链为κ链;杂交瘤细胞用无血清培养基培养,上清中抗体效价最高可达到1∶1 024 000,且经连续传代20代效价没有显著降低。Western blot及间接免疫染色检测结果显示,单克隆抗体能识别PEDV S1蛋白,并与Vero细胞、PPRV、PRRSV、PCV2、PP和CSFV等均无交叉反应,具有良好的特异性,可用于PEDV感染检测。结论 PEDV单克隆抗体的成功研制,为PEDV免疫诊断、表位识别及蛋白研究奠定了良好基础。 展开更多
关键词 猪流行性腹泻病毒 S1蛋白 单克隆抗体 免疫染色 免疫诊断
下载PDF
单克隆抗体药物中重组人透明质酸酶活性测定方法的建立
13
作者 崔春博 刘春雨 +4 位作者 于传飞 付志浩 杜加亮 王文波 王兰 《山西医科大学学报》 CAS 2023年第8期1133-1137,共5页
目的建立并验证一种检测单克隆抗体药物中重组人透明质酸酶(recombinant human hyaluronidase,rHuPH20)活性的方法。方法利用浊度法建立单克隆抗体药物中rHuPH20活性的检测方法,并对该方法的专属性、线性、中间精密度、准确度、重复性... 目的建立并验证一种检测单克隆抗体药物中重组人透明质酸酶(recombinant human hyaluronidase,rHuPH20)活性的方法。方法利用浊度法建立单克隆抗体药物中rHuPH20活性的检测方法,并对该方法的专属性、线性、中间精密度、准确度、重复性进行验证。结果该方法专属性良好,空白和不添加rHuPH20的单克隆抗体药物的rHuPH20活性均<4 U/ml。在3.5~26.7 U/ml范围内,供试品rHuPH20理论活性和实测活性线性相关,决定系数R^(2)>0.97;中间精密度试验结果的变异系数(coefficient of variation,CV)均<15%;各rHuPH20活性的平均值回收率在95%~105%之间,符合线性、中间精密度和准确度的验证要求。6次独立测定3批供试品rHuPH20活性的变异系数分别为6.56%,2.96%和4.10%,符合重复性的可接受标准(≤10%)。结论该方法各项指标均符合要求,可对单克隆抗体药物中rHuPH20活性进行质量控制。 展开更多
关键词 单克隆抗体药物 皮下注射 重组人透明质酸酶活性 浊度法 质量控制
下载PDF
抗VASN-EGFFN3重组蛋白的单克隆抗体的制备
14
作者 莫婉灵 李辉 +6 位作者 廖舟翔 温莎 黄雪静 张起 宋振宇 杨丽超 何敏 《广西医科大学学报》 CAS 2023年第4期690-696,共7页
目的:通过大肠杆菌表达系统表达和纯化VASN-EGFFNN3重组蛋白,免疫小鼠制备抗VASN-EGFFN3单克隆抗体。方法:构建p ET30a(+)-VASN-EGFFNN3重组载体,以大肠杆菌BL21(DE3)为载体表达VASN-EGFFNN3重组蛋白。用镍离子亲和层析柱纯化VASN-EGFF... 目的:通过大肠杆菌表达系统表达和纯化VASN-EGFFNN3重组蛋白,免疫小鼠制备抗VASN-EGFFN3单克隆抗体。方法:构建p ET30a(+)-VASN-EGFFNN3重组载体,以大肠杆菌BL21(DE3)为载体表达VASN-EGFFNN3重组蛋白。用镍离子亲和层析柱纯化VASN-EGFFNN3重组蛋白。利用纯化后的VASN-EGFFN3重组蛋白免疫BALB/c小鼠后,用杂交瘤技术制备抗VASN-EGFFN3单克隆抗体。结果:成功构建pET30a(+)-VASN-EGFFNN3重组原核表达质粒,诱导的重组VASN-EGFFNN3蛋白主要以包涵体的形式存在。纯化蛋白免疫BALB/c小鼠后获得的血清抗体效价大于1∶2187000,免疫效果良好。利用杂交瘤技术获得2株杂交瘤细胞株。结论:成功利用大肠杆菌表达系统制备并纯化VASN-EGFFNN3重组蛋白,通过杂交瘤技术成功制备小鼠抗VASN-EGFFN3单抗。 展开更多
关键词 VASN 单克隆抗体 重组蛋白
下载PDF
重组人源化抗人IL-6R单克隆抗体对类风湿关节炎临床疗效及骨保护的影响
15
作者 葛洪亮 柳毓文 胡建康 《中国医学创新》 CAS 2023年第24期134-137,共4页
目的:观察重组人源化抗人IL-6R单克隆抗体对类风湿关节炎临床疗效、骨保护的影响,为类风湿关节炎治疗提供更多、更积极手段。方法:选取2019年9月—2020年9月萍乡市人民医院门诊及住院就诊、确诊类风湿关节炎患者120例,按照随机数字表法... 目的:观察重组人源化抗人IL-6R单克隆抗体对类风湿关节炎临床疗效、骨保护的影响,为类风湿关节炎治疗提供更多、更积极手段。方法:选取2019年9月—2020年9月萍乡市人民医院门诊及住院就诊、确诊类风湿关节炎患者120例,按照随机数字表法分组,分为对照组和观察组。对照组为安慰剂(淀粉)+甲氨蝶呤+稳定剂量泼尼松≤10 mg/d;观察组为重组人源化抗人IL-6R单克隆抗体注射液+甲氨蝶呤+稳定剂量泼尼松≤10 mg/d,对比疗效、关节肿胀、关节压痛、骨密度、骨钙素等成果。结果:治疗3个月后,观察组的临床总有效率高于对照组(P<0.05),红细胞沉降率、类风湿因子均低于对照组(P<0.05),观察组骨密度T值、骨钙素均优于对照组(P<0.05)。观察组关节肿胀、关节压痛个数均少于对照组,观察组VAS评分及DAS28均低于对照组(P<0.05)。在治疗期间不良反应发生率上,观察组与对照组差异无统计学意义(P>0.05)。结论:在甲氨蝶呤及稳定剂量泼尼松≤10 mg/d基础上,采用重组人源化抗人IL-6R单克隆抗体对类风湿关节炎具有良好的临床疗效,还有助于改善骨保护、骨密度指标,同时不良反应较少。 展开更多
关键词 重组人源化抗人IL-6R 单克隆抗体 类风湿关节炎 骨保护
下载PDF
重组人源化抗白介素-6受体单克隆抗体对类风湿关节炎临床疗效及骨代谢的影响
16
作者 葛洪亮 谢洁 +1 位作者 柳毓文 胡建康 《中国医学创新》 CAS 2023年第26期19-23,共5页
目的:探讨重组人源化抗白介素-6受体单克隆抗体对类风湿关节炎(RA)临床疗效及骨代谢的影响。方法:选取2019年8月—2022年3月于萍乡市人民医院就诊并确诊RA患者60例,按随机数字表法将患者分为治疗组和对照组,各30例。治疗组采用重组人源... 目的:探讨重组人源化抗白介素-6受体单克隆抗体对类风湿关节炎(RA)临床疗效及骨代谢的影响。方法:选取2019年8月—2022年3月于萍乡市人民医院就诊并确诊RA患者60例,按随机数字表法将患者分为治疗组和对照组,各30例。治疗组采用重组人源化抗白介素-6受体单克隆抗体+甲氨蝶呤+稳定剂量泼尼松治疗,对照组采用甲氨蝶呤+稳定剂量泼尼松治疗。于治疗前和治疗3、6个月检测两组患者机体的C反应蛋白、类风湿因子、血沉、骨钙素(OC)、骨密度,评估两组患者的视觉模拟评分法(VAS)评分、Sharp评分及安全性。结果:两组治疗3、6个月的C反应蛋白、类风湿因子、血沉、VAS评分均明显低于治疗前(P<0.05),且治疗组治疗3、6个月上述指标均明显低于对照组(P<0.05)。两组治疗3、6个月的OC均高于治疗前(P<0.05),且治疗组治疗3、6个月OC均高于对照组(P<0.05);两组治疗前后股骨颈骨密度组间和组内比较,差异均无统计学意义(P>0.05)。两组治疗3、6个月的Sharp评分均低于治疗前(P<0.05),且治疗组治疗3、6个月的Sharp评分均低于对照组(P<0.05)。治疗组不良事件发生率虽高于对照组,但两组比较差异无统计学意义(P>0.05)。结论:重组人源化抗白介素-6受体单克隆抗体可有效降低RA患者的C反应蛋白、类风湿因子及血沉水平,缓解其疼痛,升高OC,降低Sharp评分,且不会增加不良事件的发生,安全性较高。 展开更多
关键词 重组人源化抗白介素-6受体单克隆抗体 类风湿关节炎 骨代谢
下载PDF
抗人降钙素原特异性单克隆抗体的制备鉴定及初步应用 被引量:9
17
作者 郑怡麟 何莹 +2 位作者 陈安 易维京 胡川闽 《第三军医大学学报》 CAS CSCD 北大核心 2013年第6期523-526,共4页
目的获得抗人降钙素原(procalcitonin,PCT)单克隆抗体,并鉴定其基本特性。方法从NCBI数据库中获得PCT编码序列,以原核表达系统表达PCT重组蛋白,经镍亲和层析柱纯化,获得筛选单克隆抗体的筛选原;综合应用多种生物信息学分析软件预测PCT... 目的获得抗人降钙素原(procalcitonin,PCT)单克隆抗体,并鉴定其基本特性。方法从NCBI数据库中获得PCT编码序列,以原核表达系统表达PCT重组蛋白,经镍亲和层析柱纯化,获得筛选单克隆抗体的筛选原;综合应用多种生物信息学分析软件预测PCT中潜在的B细胞表位肽,用合成肽对BALB/c小鼠进行免疫,纯化单克隆抗体,通过间接ELISA、Western blot和免疫组化鉴定获得的单克隆抗体。将获得的单克隆抗体作为捕获抗体,经过配对建立检测重组PCT的ELISA体系,并初步对临床血清进行了检测。结果成功获得3株PCT特异性单克隆抗体,分别为2-D7、2-H12和4-H12,亚类分别为IgG1和IgG2a,最高效价为1∶1 024 000,亲和力最高可达到1.3×109L/mol;选取2-D7经Western blot鉴定能够检测重组PCT蛋白,经免疫组化证实能特异性识别甲状腺组织中PCT蛋白,经过配对成功建立了检测重组PCT的ELISA体系,运用建立体系检测临床血清PCT含量时发现正常组与细菌培养阳性组之间具有显著差异。结论成功表达了人PCT重组蛋白,获得了3株高特异性和高亲和力的PCT单克隆抗体,成功建立了检测重组PCT的ELISA体系,并初步用于临床样本检测。 展开更多
关键词 降钙素原 原核表达 单克隆抗体 特性鉴定 ELSIA检测
下载PDF
抗猪圆环病毒2型Cap蛋白中和性单克隆抗体的制备及鉴定 被引量:18
18
作者 黄立平 刘长明 +3 位作者 危艳武 张朝霞 陆月华 郭龙军 《中国预防兽医学报》 CAS CSCD 北大核心 2009年第2期132-136,共5页
以纯化的杆状病毒表达的重组猪圆环病毒2型(PCV2)Cap蛋白(PCV2-rCap)免疫BALB/c小鼠,利用淋巴细胞瘤杂交技术获得了5株稳定分泌抗PCV2-rCap蛋白的杂交瘤细胞株,分别命名为1D2、2E8、3A10、5F2和6F10。这5株杂交瘤细胞诱导同品系小鼠产... 以纯化的杆状病毒表达的重组猪圆环病毒2型(PCV2)Cap蛋白(PCV2-rCap)免疫BALB/c小鼠,利用淋巴细胞瘤杂交技术获得了5株稳定分泌抗PCV2-rCap蛋白的杂交瘤细胞株,分别命名为1D2、2E8、3A10、5F2和6F10。这5株杂交瘤细胞诱导同品系小鼠产生的腹水抗体效价分别为1∶2048000、1∶512000、1∶1024000、1∶512000、1∶1024000;其中1D2、2E8、5F2和6F10单抗亚类为IgG2a,仅3A10为IgG1;2E8、3A10、5F2和6F10单抗轻链为λ型,仅1D2轻链为κ型。Western blot结果显示,这5株单抗中2E8、3A10、5F2和6F10可与自然PCV2-Cap发生反应,而1D2无反应。IPMA和抗原捕获ELISA结果表明,1D2单抗可与PCV2病毒蛋白发生反应,而与PCV1无交叉反应;病毒中和试验证实,1D2单抗具有中和活性,是一株针对PCV2-Cap蛋白中和表位的单抗。这些单抗的制备为PCV2抗原表位分析及分子诊断提供了技术手段。 展开更多
关键词 猪圆环病毒2型 重组CAP蛋白 中和活性 单克隆抗体
下载PDF
猪瘟病毒野毒株E2蛋白特异性单抗免疫抑制制备法的建立 被引量:7
19
作者 夏照和 彭伍平 +4 位作者 成丹 侯强 王万利 孙元 仇华吉 《中国兽医科学》 CAS CSCD 北大核心 2008年第9期757-761,共5页
采用环磷酰胺免疫抑制法制备特异性识别猪瘟病毒(CSFV)野毒株的单克隆抗体,用纯化的杆状病毒表达的重组HCLV-E2蛋白作为耐受原,Shimen-E2蛋白作为免疫原,免疫BALB/c小鼠,取其脾淋巴细胞与SP2/0骨髓瘤细胞融合,获得了1株能稳定分泌抗E2... 采用环磷酰胺免疫抑制法制备特异性识别猪瘟病毒(CSFV)野毒株的单克隆抗体,用纯化的杆状病毒表达的重组HCLV-E2蛋白作为耐受原,Shimen-E2蛋白作为免疫原,免疫BALB/c小鼠,取其脾淋巴细胞与SP2/0骨髓瘤细胞融合,获得了1株能稳定分泌抗E2蛋白单克隆抗体的杂交瘤细胞株,结果显示,该单克隆抗体能够与CSFV石门株发生反应,同时能与1.1、2.1、2.2和2.3基因亚群CSFV野毒发生特异性反应,并具有中和活性,而与CSFV兔化弱毒疫苗株不发生反应。表明,该单克隆抗体可以用于鉴别CSFV野毒株和兔化弱毒疫苗株。 展开更多
关键词 猪瘟病毒 E2蛋白 重组杆状病毒 单克隆抗体 免疫抑制
下载PDF
戊型肝炎病毒Ⅰ、Ⅱ与Ⅲ、Ⅳ基因型B细胞抗原表位的异同 被引量:10
20
作者 赵宇 梁久红 +4 位作者 孟继鸿 张兰芳 张红梅 丁福 季晓辉 《中国免疫学杂志》 CAS CSCD 北大核心 2004年第9期591-595,共5页
目的 :制备戊型肝炎病毒 (HEV)缅甸株和墨西哥株ORF2重组蛋白 (p16 6Bur和p16 6Mex)的单克隆抗体(McAbs) ,用于分析HEV不同基因型B细胞抗原表位的特点。方法 :将免疫BALB C小鼠脾细胞与SP2 0骨髓瘤细胞融合 ,获得分泌抗 p16 6Bur和抗 ... 目的 :制备戊型肝炎病毒 (HEV)缅甸株和墨西哥株ORF2重组蛋白 (p16 6Bur和p16 6Mex)的单克隆抗体(McAbs) ,用于分析HEV不同基因型B细胞抗原表位的特点。方法 :将免疫BALB C小鼠脾细胞与SP2 0骨髓瘤细胞融合 ,获得分泌抗 p16 6Bur和抗 p16 6MexMcAbs的杂交瘤细胞株 ,然后采用ELISA和免疫印迹法测定McAbs与不同基因型HEVORF2编码蛋白p16 6的免疫反应性。结果 :获得 4株杂交瘤细胞株 ,即分泌抗 p16 6BurMcAbs的 2C2 、2B1 以及分泌抗 p16 6MexMcAbs的D8G1 0 和E5E1 2 ,其中 2B1 分泌的McAb仅能与第Ⅰ、Ⅱ基因型编码的重组蛋白结合 ,而其余 3株分泌的McAbs既能与I、II基因型HEV的p16 6重组蛋白发生反应 ,也能与III、IV基因型的p16 6蛋白反应。结论 :HEV第Ⅰ、Ⅱ基因型与Ⅲ、Ⅳ基因型ORF2编码蛋白既有共同又有不同的B细胞抗原表位。 展开更多
关键词 戊型肝炎病毒 抗原表位 单克隆抗体 重组蛋白 基因型
下载PDF
上一页 1 2 11 下一页 到第
使用帮助 返回顶部